Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Relentless Improvement was a U.S.-based nutraceutical company and direct-to-consumer supplement brand focused on manufacturing and marketing natural-ingredient nutritional supplements. Public business-directory sources describe its portfolio as covering anti-aging, antioxidant, bone health, cognitive support, blood sugar, sleep, thyroid, inflammation, eye health, and weight-management categories, with dozens of commercial products. The business appears to have sold primarily through its own website and online marketplaces rather than through a drug-development model. Although it is healthcare-related in the broad consumer-health sense, it does not appear to be a biotech or pharmaceutical therapeutics developer with a clinical pipeline. Corporate registry aggregators indicate the Nevada legal entity was dissolved, even though the brand and products have continued to appear in online commerce listings.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Relentless Improvement.